Evolving payer policies toward oncology therapeutics are rapidly creating barriers to access for cancer patients. focalPoint changes the way Biotech/Pharmaceutical manufacturers approach Access and Reimbursement by identifying opportunities and challenges with real-time data from a unique and differentiated data source.
Using focalPoint, subscribers are able to distinguish between provider versus payer related claims issues. focalPoint will identify and prioritize the metrics used to monitor payer policy toward access and reimbursement for electronically filed claims at all payer types.
focalPoint will also provide benchmarking data at the national, state or specific plan level in order to establish a value story around positive access and reimbursement, that allows for a targeted approach to identified payer specific challenges.
focalPoint tracks denial rates, reasons for denial, amounts allowed and paid by the payer, time to file, time to payment, patient responsibility, and continuous tracking of specific provider and payer roadblocks.
focalPoint is set apart from other current market offerings by the additional service attached to our unique data. focalPoint provides for collaboration with a team of experts possessing unprecedented oncology specific access and reimbursement expertise along with regular reporting to provide interpretation, strategy and tactics to the data tools.
By offering unprecedented access to a targeted network of physicians and administrators , intelliPoint® supports Hem / Onc brands by helping them adapt to the changing market of oncology care.